Sun, Nov 23, 2014, 11:27 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • vvvvvvrebel89130 vvvvvvrebel89130 Feb 28, 2013 3:18 PM Flag

    gsk failure impact on srpt

    1. no competition; clears the decks for srpt
    2. gsk's failure might make the fda more reluctant to approve aa without additional trials; fda doesn't want another failure on their hand

    looks like someone was caught off-guard by the gsk news even tho it is fairly old and wanted in, especitally in front of 2 presentations next week

    fda meeting held; awaiting minutes

    Sentiment: Strong Buy

 
SRPT
15.73-0.05(-0.32%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.